Concepedia

Author

Xavier Pouwels

Maastricht University Medical CentreORCID

Also Known As

Bram Ramaekers, Pouwels, X, Pouwels, X. G. L. V., Pouwels, Xavier G. L. V., X Pouwels, X. G. L. V. Pouwels, X. Pouwels, X.G.L.V. Pouwels, XG Pouwels, Xavier G L V Pouwels

60

Publications

425

Citations

12

H-Index

12

Concepts

All Affiliations

Maastricht University Medical CentreRadboud University NijmegenMaastricht UniversityUniversity of TwenteUniversity of Sheffield
XP

About

Xavier Pouwels is an author at Maastricht University Medical Centre specializing in decision science, evidence-based practice, and economic evaluation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Education

1

1

21

2

Public Health

1

1

26

3

Health Policy

1

1

26

4

Health Economics

1

1

26

5

Professional Development

1

1

21

Xavier Pouwels

×

9

Publications

202

Citations

9

H-Index

YearCitations

Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models

Sabine Grimm, Xavier Pouwels, Bram Ramaekers,

PharmacoEconomics

2019

39

Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?

Martijn J. Oude Wolcherink, Xavier Pouwels, Sanne H B van Dijk,

Expert Review of Pharmacoeconomics & Outcomes Research

2023

38

Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease

Xavier Pouwels, Dominique van Mil, Lyanne M. Kieneker,

EClinicalMedicine

2024

28

Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey

Xavier Pouwels, Chris Sampson, Renée J.G. Arnold,

Value in Health

2022

26

Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?

Xavier Pouwels, Janneke P.C. Grutters, Jill Bindels,

Value in Health

2019

21

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands

P. Schneider, Xavier Pouwels, Valéria Lima Passos,

PLoS ONE

2020

15

Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study

Svenja Petersohn, Xavier Pouwels, Bram Ramaekers,

European Journal of Preventive Cardiology

2020

14

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands

P. Schneider, Bram Ramaekers, Xavier Pouwels,

Value in Health

2021

11

Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model

Ingrid Kremer, Mickaël Hiligsmann, Josh J. Carlson,

Medical Decision Making

2020

10

Page 1